Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Kevin G Lynch"'
Autor:
Zhenhao Shi, Xinyi Li, Dustin R. Todaro, Wen Cao, Kevin G. Lynch, John A. Detre, James Loughead, Daniel D. Langleben, Corinde E. Wiers
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Opioid use disorder (OUD) has been linked to macroscopic structural alterations in the brain. The monthly injectable, extended-release formulation of μ-opioid antagonist naltrexone (XR-NTX) is highly effective in reducing opioid craving and
Externí odkaz:
https://doaj.org/article/3957f5eb13724d4e8618862cc4e14840
Autor:
Frederick Nitchie, Abigail Casalvera, Marta Teferi, Milan Patel, Kevin G. Lynch, Walid Makhoul, Yvette I. Sheline, Nicholas L. Balderston
Publikováno v:
Mental Health Science, Vol 2, Iss 3, Pp n/a-n/a (2024)
Abstract Past research has shown that the bilateral dorsolateral prefrontal cortices (dlPFC) are implicated in both emotional processing as well as cognitive processing,1,2,3 in addition to working memory4, 5. Exactly how these disparate processes in
Externí odkaz:
https://doaj.org/article/f3857a54687947e5b48143a60cd890ca
Autor:
Brittany E. Blanchard, Kevin G. Lynch, Carol A. Malte, Eric J. Hawkins, Dominick DePhilippis, David W. Oslin, James R. McKay, Andrew J. Saxon
Publikováno v:
Drug and Alcohol Dependence Reports, Vol 8, Iss , Pp 100183- (2023)
Introduction: The Brief Addiction Monitor-Revised (BAM-R) is a widely used, 17-item assessment of substance use, risk, and protective factors associated with recovery from substance use disorders. Despite wide adoption in the U.S. Department of Veter
Externí odkaz:
https://doaj.org/article/686cf858cea444ada5c9b005233b5a7b
Autor:
Xinyi Li, Daniel D. Langleben, Kevin G. Lynch, Gene-Jack Wang, Igor Elman, Corinde E. Wiers, Zhenhao Shi
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundExcessive consumption of opioids is associated with impaired metabolic function including increased body mass index (BMI). Opioid antagonist naltrexone (NTX) is an effective treatment for opioid use disorder (OUD) that has the potential to
Externí odkaz:
https://doaj.org/article/cb9c2b20767a4c27a0e8403378013518
Publikováno v:
Journal of Affective Disorders. 327:368-377
Autor:
David P. Cenkner, Anu Asnaani, Christina DiChiara, Gerlinde C. Harb, Kevin G. Lynch, Jennifer Greene, J. Cobb Scott
Publikováno v:
Frontiers in Psychology, Vol 12 (2021)
BackgroundPost-traumatic stress disorder (PTSD) is a prevalent, debilitating, and costly psychiatric disorder. Evidenced-based psychotherapies, including Cognitive Processing Therapy (CPT), are effective in treating PTSD, although a fair proportion o
Externí odkaz:
https://doaj.org/article/12291ebdc96345f09383b4232e97c36a
Autor:
Zhenhao Shi, Xinyi Li, Juliana I. Byanyima, Charles P. O’Brien, Anna Rose Childress, Kevin G. Lynch, James Loughead, Corinde E. Wiers, Daniel D. Langleben
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 49:180-189
Autor:
Zhenhao Shi, An‐Li Wang, Victoria P. Fairchild, Catherine A. Aronowitz, James H. Padley, Kevin G. Lynch, James Loughead, Daniel D. Langleben
Publikováno v:
Addiction. 118:914-924
Graphic warning labels (GWLs) on cigarette packs have been adopted by many jurisdictions worldwide. In the US, the introduction of GWLs has been delayed by claims that their high level of negative emotional arousal unnecessarily infringed on the toba
Autor:
James R. McKay, David H. Gustafson, Megan Ivey, Fiona McTavish, Klaren Pe-Romashko, Brenda Curtis, David A. Oslin, Daniel Polsky, Andrew Quanbeck, Kevin G. Lynch
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-15 (2018)
Abstract Background New smartphone communication technology provides a novel way to provide personalized continuing care support following alcohol treatment. One such system is the Addiction version of the Comprehensive Health Enhancement Support Sys
Externí odkaz:
https://doaj.org/article/0b728795ae684b368cd75524c5f6a99b
Autor:
Chamindi Seneviratne, David A. Gorelick, Kevin G. Lynch, Clayton Brown, Danielle Romer, Timothy Pond, Kyle Kampman, Henry R. Kranzler
Publikováno v:
Alcoholism: Clinical and Experimental Research. 46:1900-1912
In a previous study, ondansetron, a serotonin 5-HTIn this 16-week, double-blind, placebo-controlled, parallel-group clinical trial, adults with AUD were randomized to receive low-dose oral ondansetron (0.33 mg twice daily) or placebo stratified by "r